Intrinsic Value of S&P & Nasdaq Contact Us

Janux Therapeutics, Inc. JANX

NASDAQ Global Market

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.80
+161.2%

Janux Therapeutics, Inc. (JANX) current share price is $15.24. The gold spot price is $4,825.20 per troy ounce. Using the formula: JANX in gold = $15.24 × 31.1035 ÷ $4,825.20 = 0.0982 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of JANX when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding JANX shares over the measured period.

JANX in US Dollars
Gold in US Dollars
JANX in Gold (grams per share)

Real Wealth Growth Rate

JANX
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{JANX}_{\text{gold}}(t) = \frac{P_{\text{JANX}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{JANX}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{JANX}_{\text{gold}}^{(T)}}{\text{JANX}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{JANX}_\text{gold}^{(0)}$ = initial gold-price, $\text{JANX}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
HRMY
HRMY
Harmony Biosciences Holdings, Inc.
$29.29
+0.83%
KROS
KROS
Keros Therapeutics, Inc.
$11.55
+3.59%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
FENC
FENC
Fennec Pharmaceuticals Inc.
$6.25
+5.40%
MOLN
MOLN
Molecular Partners AG
$4.14
-1.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message